Spago Nanomedical
LUND, SWEDEN / ACCESSWIRE / December 6, 2021 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F)
Spago Nanomedical AB (publ) today announced it has completed the studies in the regulatory preclinical program with its leading candidate drug Tumorad (SN201). It displays a good safety margin to clinically relevant doses.
"The completion of the regulatory preclinical studies is an important step towards the clinical development phase. The preparations for the first study with SN201 in humans are proceeding according to plan and we expect to be ready to start phase I/II in next year ", said CEO Mats Hansen.
The preclinical package included toxicology- and dosimetry-studies in rat. The results showed that the nanomaterial is safe to give in doses that widely exceed planned clinical doses, and that radiation is distributed in the body in a manner that allow dosing according to plan.
"The results confirm the data we previously have seen in pilot studies and mean that we with confidence can proceed with SN201 to the clinic. This is a major risk reduction in the project ", said Oskar Axelsson, CSO at Spago Nanomedical.
Data from the preclinical studies, together with other documentation, will form the basis for the first clinical trial application with Tumorad. The plan is to submit the application and start the studies in humans in 2022. The aim for the clinical study is to document safety at different doses of Tumorad in cancer patients as well as to evaluate signs of early proof-of-concept.
The preclinical regulatory program, conducted in collaboration with Charles River Laboratories and Minerva Imaging, included both toxicity and dosimetry studies.
For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se
Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.
FNCA Sweden AB is the Certified Adviser of the company, +46 8 528 00 399, info@fnca.se .
This information is information that Spago Nanomedical is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2021-12-06 08:00 CET.
Attachments
Tumorad® shows good safety in preclinical studies
SOURCE: Spago Nanomedical
View source version on accesswire.com:
https://www.accesswire.com/676127/TumoradR-Shows-Good-Safety-in-Preclinical-Studies
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards16.12.2025 15:00:00 CET | Press release
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding contribution at the recent OMP Conference. The four industry leaders were honored at the Miami event for their commitment to innovation and excellence, while driving real-world results across their global operations. The OMP Awards program turns the spotlight on organizations within the OMP Community that set new benchmarks in supply chain planning and inspire cross-industry progress and transformation. Eastman: Co-shaping Unison Planning™ in a long-term partnership A strategic OMP customer for nearly two decades, Eastman received the Long‑Term Partnership Award for co‑shaping the chemical industry solution of Unison Planning™. Eastman's vision and intense collaboration have helped redefine best practices in chemical supply chain planning and have been a positive influence on broader industry standards. Accepting the award, Baptiste Lebreton, Digi
The U.S. Polo Assn. Palm Beaches Marathon Celebrates Record-Breaking Weekend in West Palm Beach, Florida16.12.2025 13:00:00 CET | Press release
Thousands of Runners From Around the World Participate in South Florida Race Weekend, With Ivan Gabriel Mafla Bolanos of Ecuador Finishing First Overall WEST PALM BEACH, FLA. / ACCESS Newswire / December 16, 2025 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly celebrated an unforgettable race weekend as first-time Title Sponsor of the 2025 U.S. Polo Assn. Palm Beaches Marathon. The race weekend brought extraordinary energy to Downtown West Palm Beach, powered by more than 6,100 participants, representing 29 countries and 46 states. The race, a Boston Marathon qualifier, was supported by more than 200 dedicated volunteers, including employees from USPA Global, the company that manages the global, multi-billion-dollar U.S. Polo Assn. brand. The U.S. Polo Assn. Palm Beaches Marathon was broadcast live for five hours by the Official Broadcast Station, WPBF 25 (ABC, West Palm Beach). The U.S. Polo Assn. Palm Beaches Marathon was won by Ivan
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders16.12.2025 07:30:00 CET | Press release
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New Zealand-based intelligence company for brand builders and experience creators. This collaboration marks an exciting step in Market Logic's expansion across APAC, particularly in New Zealand and Australia, where Matter is working closely with local brands that want to deepen their customer and market understanding. Together, Market Logic and Matter will empower APAC businesses to uncover unique insights faster and take swifter action. By combining the power of Market Logic's AI-powered insights platform, DeepSights, with the data, research and measurement expertise of Matter, the two companies will help ambitious local brands drive international growth through intelligence. "New Zealand and Australia are home to exceptional brands who are no strangers to innovation and creativity," said Oliver Allen. "B
AI and Cybersecurity Leader, SecureAuth, Appoints Geoffrey Mattson to Help Enterprises Secure Complex Human, Machine, and AI-agent Identities10.12.2025 17:30:00 CET | Press release
IRVINE, CALIFORNIA / ACCESS Newswire / December 10, 2025 / SecureAuth, a leader in AI-driven identity security, today announced the appointment of Geoffrey Mattson as Chief Executive Officer. Mattson's appointment marks the beginning of the company's next phase of growth as enterprises confront a rapid rise in AI agents with real authority, a shift that is increasing the complexity of business relationships and driving urgent demand for modern identity security. The Board of Directors thanks outgoing CEO Joseph Dhanapal, who will remain as a strategic advisor. During his tenure, SecureAuth invested heavily in creating a next generation security platform, featuring our market leading, AI-driven risk engine. With this platform in place, SecureAuth is positioned to capture accelerating demand for identity and access management as agentic AI transforms identity from a static access check into a dynamic control plane for managing complex human, machine, and AI-driven relationships. Mattson
Nasdaq Verafin Joins Global Anti-Scam Alliance10.12.2025 15:00:00 CET | Press release
THE HAGUE, NL / ACCESS Newswire / December 10, 2025 / The Global Anti-Scam Alliance (GASA) is pleased to announce that Nasdaq Verafin has joined GASA as a Foundation Member, strengthening the global effort to combat scams, financial crime, and digital fraud. As fraud tactics continue to evolve across borders and digital channels, cross-sector collaboration has become essential to protecting consumers and building safer financial ecosystems. Nasdaq Verafin's participation marks a meaningful step forward in the shared mission to advance trust, transparency, and resilience across the globe. In addition to joining the global effort, Nasdaq Verafin will join both the Brazil and Mexico chapters of GASA to partner with stakeholders across the financial ecosystem in Latin America, bolstering regional initiatives to combat financial crime. "Criminals are innovating at an unprecedented rate, taking advantage of information siloes and the shortcomings of legacy technology to avoid detection. We a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom